Fulcrum Wealth Advisors »

Catalyst Pharmaceutical Partners shares owned by Fulcrum Wealth Advisors

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Fulcrum Wealth Advisors from 13F filings

Historical chart of Fulcrum Wealth Advisors investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Fulcrum Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Fulcrum Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $255k 11k 23.34

More positions owned by Fulcrum Wealth Advisors

Etfs Gold Tr Physcl Gold Shs (SGOL)
Sprott Asset Management Physical Gold Tr (PHYS)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Amazon (AMZN)
Alphabet Cap Stk Cl C (GOOG)
Cummins (CMI)
International Business Machines (IBM)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Broadcom (AVGO)
Ge Aerospace Com New (GE)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Mitsubishi Ufj Finl Group In Sponsored Ads (MUFG)
Apple (AAPL)

View all positions for Fulcrum Wealth Advisors

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management
Northern Trust

View all funds holding Catalyst Pharmaceutical Partners